thelancet.com
Jun 12, 2025, 05:36
The Lancet Haematology – Extended Anticoagulation in Children with VTE: New Insights from the EINSTEIN-Jr Trial
The Lancet Haematology shared on X:
“A cohort study within the EINSTEIN-Jr trial explores extended-phase anticoagulation for acute VTE in children:
Key factors: symptomatic index VTE, unprovoked VTE, & residual thrombosis.
Low risk of recurrent VTE & no major bleeding.”
Title: Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.
Autors: Christoph Male, Anthonie W A Lensing, Anthony K C Chan, Gili Kenet, Guy Young, Rukhmi Bhat, Akos F Pap, Dagmar Kubitza, Martin H Prins, Paul Monagle.
Here are some of the most compelling recent updates on Hemostasis Today
Akos F Pap
Anthonie W A Lensing
Anthony K C Chan
Anticoagulation Safety
Bleeding Risk in Children
Christoph Male
Dagmar Kubitza
EINSTEIN-Jr Trial
Extended-phase Anticoagulation
Gili Kenet
Guy Young
Headlines
Hemostasis Today
Martin H Prins
Paul Monagle
Pediatric Hemostasis
Pediatric Venous Thromboembolism
Recurrent Thrombosis Risk
Residual Thrombosis
Rukhmi Bhat
Symptomatic VTE
The Lancet Haematology
Unprovoked VTE in Children
-
Jul 30, 2025, 17:44Ami Bhatt: Fiber — Nature’s Strongest Weapon Against Heart Disease
-
Jul 30, 2025, 17:19Erin VanDyke Congratulates IU Health on Joining the NBCA COE Program
-
Jul 30, 2025, 16:51EHC Youth Fellowship Internship—Apply by August 4
-
Jul 30, 2025, 16:37Randolph B Lyde Jr. Joins ASH Hematology Trainee Council
-
Jul 30, 2025, 13:32Kathleen Freson Invites You to Apply for ISTH SSC Subcommittee Co-Chairs by July 31
-
Jul 30, 2025, 16:24Cedric Hermans Invites You to Explore Hematologie Edition 2025 Nº 04
-
Jul 30, 2025, 15:53Robert Sidonio on the Role of aPCC in Patients Receiving Emicizumab Prophylaxis
-
Jul 30, 2025, 14:53William Aird on Hematological Manifestations of Anorexia Nervosa
-
Jul 30, 2025, 14:04Leonard Valentino On The Bleeding Disorders Research Collaborative
-
Jul 29, 2025, 13:22Patent Foramen Ovale and Stroke: A JAMA Review of Management
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 28, 2025, 12:53Zambia’s Hemophilia Prophylaxis Success
-
Jul 26, 2025, 16:14Cesar Garrido: Forging Strong Partnerships on WHA78 ''Global Health Equity'' Event
-
Jul 23, 2025, 15:34Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
-
Jul 23, 2025, 11:05Haemnet Gives Voice to Parents Facing the Challenges of Childhood Bleeding Disorders
-
Jul 23, 2025, 10:43From Blood Clot Survivor to NFL History: Trey Smith’s Record Deal
Jul 30, 2025, 17:44
Jul 30, 2025, 17:19
Jul 30, 2025, 16:51
Jul 30, 2025, 16:37
Jul 30, 2025, 16:24
Jul 30, 2025, 14:53
Jul 30, 2025, 14:04
Jul 29, 2025, 16:31
Jul 29, 2025, 15:53